Vijay Samant

Biography

Mr. Samant has served as a member of the Company’s board of directors since November 2015. Since November 2000, he has served as President and CEO of Vical, Inc., a developer of biopharmaceutical products for the prevention and treatment of chronic life-threatening infectious diseases.  Prior to Vical, Mr. Samant gained more than two decades of U.S. and international sales, marketing, operations and business development experience at Merck & Co, serving as COO of the Merck Vaccine Division, VP of Vaccine Operations, VP of Business Affairs and Executive Director of Materials Management.  Mr. Samant has served on the boards of Raptor Pharmaceuticals, BioMarin, Aeras Global TB Vaccine Foundation and the International Vaccine Institute.  He also served on the Board of Trustees of The National Foundation for Infectious Diseases.  He holds a Bachelor’s degree in Chemical Engineering from the University of Bombay, a Master’s degree in Chemical Engineering from Columbia University and a Master’s in Management Studies from the Sloan School of Management at the Massachusetts Institute of Technology.

Research Interest

clinical research